A number of studies have been undertaken to assess the importance of shortened red cell survival in the causation of anaemia complicating rheumatoid arthritis. Freireich, Ross, Bayles, Emerson, and Finch (1954) , using the Ashby technique, found reduction of the life span of transfused erythrocytes from normal individuals in patients suffering from the disease. Alexander, Richmond, Roy, and Duthie (1956) , using the same technique, confirmed this observation in all of eighteen patients, as did McCrea (1957) in ten out of fifteen patients and Freireich, Ross, Bayles, Emerson, and Finch (1957) in "more than half" of thirteen patients. However, Freireich and others (1954, 1957) observed that cells from patients with rheumatoid arthritis survived normally in the circulation of normal individuals; Alexander and others (1956) reported that the survival time of cells from patients with rheumatoid arthritis, although shorter than normal, exceeded that of cells from normal subjects when transfused to other patients with rheumatoid arthritis.
The survival of a patient's own cells in his own circulation cannot be measured by the Ashby technique. Hence it is interesting to review the evidence for a haemolytic process in rheumatoid arthritis that has been obtained with the use of chromium-51 as a red cell label. Bunim (1954) reported the first such study and observed reduction of the survival time of the patients' own cells in all the cases investigated. This was confirmed in a report by Ebaugh, Peterson, Rodnan, and Bunim (1955) . Weinstein (1959) , also measuring the survival of the patient's own cells in his own circulation, stated that "hyperhaemolysis" contributes to the anaemia of rheumatoid arthritis. However, a study of his data shows that nine of the eighteen patients investigated fell within the normal range of the author's series and that in only four patients (two of whom had splenomegaly) was the rate of disappearance of injected radioactivity clearly increased. Lewis and Porter (1960) used chromium-51 in a study of fifty patients; in only four was survival of the individual's own cells (after correction for elution of chromium) below the normal range, and in these patients the finding appeared to be due to a loss of radioactivity from the circulation, in the first few days of the study, slightly greater than that which is known to occur in normal subjects. These authors, who took care to exclude gastro-intestinal bleeding as a cause of loss of labelled red cells from the circulation, concluded that "haemolysis is not a feature of rheumatoid arthritis and is not a significant factor in the development of the anaemia which is often associated with the disease".
Because of the divergent results of different investigators, it was considered that the following report, which deals with the survival of the subject's own cells and of donor cells from normal individuals in patients with rheumatoid arthritis, would be of interest. The preliminary findings in this investigation have been reported elsewhere (Richmond, 1957) . Methods 21 patients suffering from rheumatoid arthritis were investigated; in each patient the diagnosis of "definite rheumatoid arthritis" had been established by the criteria recommended in the revised classification of the American Rheumatism Association (Ropes, 1959) . All were receiving in-patient treatment at the Rheumatic Diseases Unit, Northern General Hospital, Edinburgh.
The patients were unselected; none showed an unusually severe degree of anaemia, clinical evidence of haemolytic disease, or palpable splenic enlargement.
The survival of the patient's own red cells in his own circulation was studied in each case, and in six of the patients the survival of cells freshly withdrawn from compatible healthy donors was also measured.
In five normal individuals the measurement of survival of the subject's cells in his own circulation was used as a standard of normality.
Red cell survival was estimated using the radioactive isotope chromium 51 as a red cell label; the method was that described by Mollison and Veall (1955) . Because of the elution of chromium from labelled cells (approximately 1 per cent. per day) it is accepted that the rate of disappearance of injected radioactivity from the patient's circulation can only serve as an index of cell survival. No attempt has been made to correct the results in the present investigation for elution. The first blood sample was withdrawn 1 hour after the injection of chromiumlabelled cells and its content of radioactivity constituted the initial level of "100 per cent.". Two further samples of blood were withdrawn in the next 3 days; thereafter samples were obtained twice weekly for at least 20 days.
The methods for determining the peripheral blood counts, the erythrocyte sedimentation rate (E.S.R.), and the agglutination titre of sensitized sheep cells (S.S.C.T.) have been described in previous communications (Richmond, Gardner, Roy, and Duthie, 1956; Bremner, Alexander, and Duthie, 1959) .
Results
Clinical and Haematological Status of Patients.-Eleven female and ten male patients were investigated. Clinical and other data on these patients are shown in Table I .
There was a wide range for age, clinical duration of disease, haemoglobin level, erythrocyte sedimentation rate, and agglutination titre for sensitized sheep cells.
Erythrocyte Survival.-As a measure of "cell survival" the linear regression coefficient (b) of radioactivity (log. percentage of initial radioactivity) on time (in days) was calculated for the data obtained in each patient. In each case there was a high linear correlation between remaining radioactivity and time (correlation coefficient, r = -0*9361 to -0*9985) within the period after injection during which the rate of disappearance was calculated. A plot of the data showed that the relationship was not strictly linear in some cases, but within the chosen limits of 0 to 20 days the linear coefficients were adequate for the purpose of comparing "cell survival" in different individuals and groups.
The following results are summarized in Table II (a) Own Cells in Normal Subjects.-The average linear regression coefficient (b) for the five normal subjects studied was -0 0107 (r = -0'9937). These results are similar to those of Mollison and Veall (1955) (Freireich and others, disorder. TI 1954, 1957) suggests that the disorder is due to some investigation extracorpuscular factor rather than to an intrinsic rheumatoid abnormality in the erythrocyte.
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However, when cells from normal donors were transfused into six of the patients with rheumatoid arthritis, the rate of disappearance of injected radioactivity was faster than when the survival of the patients' own cells was measured and significantly faster than in normal subjects. Mollison (1959) has drawn attention to the misleading results which can arise in cross-transfusion experiments and are presumably due to incompatibility which has not been detected by the usual in vitro tests. However, this explanation seems unlikely to obtain in the present investigation. Not onlywouldincompatability be expected to lead to a much greater increase in the rate of red cell destruction than has been observed, but also the finding of accelerated destructic n of normal donor cells compared with the patients' own cells confirms our previous results (Alexander and others, 1956) 
SummarY
(1) The literature relating to red cell survival in patients suffering from rheumatoid arthritis has been reviewed.
(2) The survival of the subject's own cells has been measured using radioactive chromium in 21 patients suffering from rheumatoid arthritis. In six of these the survival of normal donor erythrocytes was also measured.
(3) The rate of removal of injected radioactivity from the circulation was slightly, but not significantly, more rapid than normal when the patients' cells were labelled. The rate of elimination of labelled donor erythrocytes was significantly faster than normal.
(4) It is concluded that there is a mild haemolytic process of extracorpuscular type in rheumatoid disease.
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Nature de l'ankmie dans P'arthrite rhumatismale. V. Survie des globules rouges mesuree par le chrome radioactif RESUME (1) On passe en revue la litterature concernante la survie des globules rouges des malades atteints d'arthrite rhumatismale.
(2) La survie des erythrocytes propres du sujet fut mesurde a I'aide du chrome radioactif chez 21 malades atteints d'arthrite rhumatismale. Chez six d'entre eux on mesura aussi la survie des globules rouges provenant d'un donneur normal.
(3) Le taux d'elimination de la radioactivity injected de la circulation fut legerement mais non pas appreciablement au dessus de la normale en ce qui concerne les globules marques propres du malade. Le velocity d'elimination des globules marques du donneur fut appreciablement augmentee.
(4) On conclut que dans la maladie rhumatismale il existe un benin processus hemolytique du type extracorpusculaire.
Naturaleza de la anemia en la artritis reumatoide. V. Superviviencia de los hematies medida con cromo radioactive SUMARIO (1) Se pasa en revista la literature referente a la superviviencia de hematies de enfermos con artritis reumatoide.
(2) La superviviencia de los eritrocitos propios del sujeto se midi6 por medio de cromo radioactive en 21 enfermos con artritis reumatoide. En seis de estos se midi6 tambien la superviviencia de hematies procedentes de donante normal.
(3) La velocidad de desaparici6n de la radioactividad inyectada de la circulaci6n fue ligeramente pero no apreciablemente superior a la normal en el caso de eritrocitos propios del paciente. Los eritrocitos marcados de donante sano fueron eliminados con rapidez apreciablemente superior a la normal.
(4) Se concluye que en la enfermedad reumatoide existe un ligero proceso hemolitico del tipo extracorpuscular.
